My guess is this stuff happening (new bill plus O'Neill) will hand more pore power to later stage gatekeepers. Now the main gatekeeper is FDA with an assist by formulary setters and doctor thought leaders. These changes will move the line toward those who decide what is covered - doctors, hospitals, govt, insureres.
By the way, it is unclear to me but this might hurt pricing power giving more power to that group.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.